Balaxi Pharmaceuticals Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026. The certificate was received from the company's Registrar and Share Transfer Agent, M/s. Aarthi Consultants Private Limited. This compliance filing confirms that Aarthi Consultants Private Limited has processed the dematerialization of securities within the stipulated 15-day period from receipt. Actions taken include mutilating and canceling certificates of security forwarded by participants, and updating the records to reflect the depository as the registered owner. The dematerialized securities are listed on the stock exchange. The company has also stated that this certificate will be made available on the company's official website, www.balaxipharma.in.
